SUBSCRIBE
SUBSCRIBE

New Jersey

Pictured: FDA Headquarters, iStock, Grandbrothers
FDA
Phathom Scores Non-Erosive GERD Approval for Heartburn Drug
Already approved for erosive gastroesophageal reflux disease, Phathom’s Voquenza is now authorized to treat patients with non-erosive GERD.
July 18, 2024
 · 
1 min read
 · 
Kate Goodwin
Johnson & Johnson's business center in Switzerland
Earnings
Touting Shockwave’s Billion-Dollar Potential, J&J Lifts 2024 Guidance
Fresh off its $13-billion acquisition of medical devices developer Shockwave Medical, Johnson & Johnson is expecting greater business growth in the future.
July 18, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Navigator Medicines Announces First Participants Dosed in a Phase 1b Trial of NAV-240, a Potential Best-in-Class Anti-OX40L and Anti-TNFα Bispecific Antibody Therapeutic for Autoimmune Diseases
May 29, 2025
 · 
3 min read
Press Releases
Patritumab Deruxtecan Biologics License Application for Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Voluntarily Withdrawn
May 29, 2025
 · 
13 min read
Press Releases
CytoSorbents to Participate at the 2025 Jefferies Global Healthcare Conference
May 29, 2025
 · 
6 min read
Press Releases
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 29, 2025
 · 
4 min read
Press Releases
U.S. FDA Accepts New Drug Application Under Priority Review for sevabertinib (BAY 2927088) in HER2-Mutant Non-Small Cell Lung Cancer
May 29, 2025
 · 
7 min read
Press Releases
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
May 28, 2025
 · 
5 min read
Press Releases
Octapharma Releases Results for Phase 3 Superiority Study of Pediatric Acute-onset Neuropsychiatric Syndrome
May 28, 2025
 · 
6 min read
Press Releases
Mitsubishi Tanabe Pharma America Announces U.S. FDA Acceptance of New Drug Application Resubmission for Investigational ND0612 for the Treatment of Motor Fluctuations in Parkinson’s Disease
May 28, 2025
 · 
3 min read
Press Releases
Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
May 28, 2025
 · 
19 min read
Press Releases
Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 28, 2025
 · 
1 min read
Press Releases
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
May 28, 2025
 · 
10 min read
Press Releases
BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting
May 28, 2025
 · 
2 min read
Press Releases
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference
May 28, 2025
 · 
1 min read
Press Releases
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
May 28, 2025
 · 
4 min read
Press Releases
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
May 28, 2025
 · 
14 min read
Press Releases
IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025
May 28, 2025
 · 
9 min read
Press Releases
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
May 27, 2025
 · 
1 min read
Press Releases
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
May 27, 2025
 · 
1 min read
Press Releases
UroGen Pharma to Present at TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA
May 27, 2025
 · 
1 min read
Press Releases
Merck Announces Third-Quarter 2025 Dividend
May 27, 2025
 · 
2 min read
Load More